Icon (ICLR) Gets a Buy from Truist Financial

In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Icon. The company’s shares closed yesterday at $192.60.

Elevate Your Investing Strategy:

• Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Singh covers the Healthcare sector, focusing on stocks such as Veeva Systems, Hinge Health, Inc. Class A, and Icon. According to TipRanks, Singh has an average return of -11.6% and a 38.41% success rate on recommended stocks.

In addition to Truist Financial, Icon also received a Buy from William Blair’s Max Smock in a report issued today. However, on the same day, Barclays maintained a Hold rating on Icon (NASDAQ: ICLR).

Based on Icon’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $2.02 billion and a net profit of $182.97 million. In comparison, last year the company earned a revenue of $2.12 billion and had a net profit of $146.91 million

Based on the recent corporate insider activity of 18 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ICLR in relation to earlier this year.